
Melvin LK CHUA | FRCR, PhD, FASCO
@drmlchua
Chair, HN&Thorax Cancers | Clinician-Scientist @NCCS | FASCO @ASCO | Clinical Trials Chair @HNCIG | Commissioner @ICRU_org | Trustee @Alicesarc
ID: 832473385871384576
http://www.chualabnccs.com 17-02-2017 06:14:56
2,2K Tweet
1,1K Takipçi
347 Takip Edilen

The field of #HeadNeckCancer just got more interesting! #ASCO2025 #Plenary NIVO-POSTOP study was an important IIS for high risk HNSCC Positive DFS @ 3y But signal is primarily locoregional control! Stark contrast to KN689 Kudos to GORTEC Pierre Blanchard, MD Thoughts??
